'Leap forward' in tailored cancer medicine

Friday, 11 November 2022newsdesk
'Leap forward' in tailored cancer medicine
People with untreatable cancers have had their immune system redesigned to attack their own tumours.

New Delhi, 11 November 2022                                              

As per news report of BBC, the experimental study involved only 16 patients, but has been called a "leap forward" and a "powerful" demonstration of the potential of such technology. Each person had a treatment developed just for them, which targeted the specific weak spots in their tumour. It is too early to fully assess the therapy's effectiveness and is expensive and time-consuming.

Source -BBC

Read More >>

If you like the story and if you wish more such stories, support our effort Make a donation.